Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Aspirin and multiple sclerosis.
The therapeutic value of yoga in neurological disorders.
A review of the sheep-multiple sclerosis connection.
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Riluzole.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson's disease - what is the evidence?
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Control of TH17 cells occurs in the small intestine.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Antidepressant activity of fingolimod in mice.
No Help from Dalfampridine in MS-Related Optic Neuritis
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
Early development of anti-natalizumab antibodies in MS patients.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Atypical forms of optic neuritis.
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine.
Pages
« first
‹ previous
…
224
225
226
227
228
229
230
231
232
…
next ›
last »